— Know what they know.
Not Investment Advice

ARCT NASDAQ

Arcturus Therapeutics Holdings Inc.
1W: -10.3% 1M: -18.6% 3M: -8.5% YTD: +12.3% 1Y: -44.7% 3Y: -75.3% 5Y: -75.7%
$7.03
+0.01 (+0.14%)
 
Weekly Expected Move ±8.9%
$6 $7 $7 $8 $9
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 26 · $199.8M mcap · 26M float · 1.83% daily turnover · Short 65% of daily vol

📊 Key Metrics

TTM
$45M
Revenue
-66.4% YoY
$-79M
Net Income
-15.4% YoY
$-59M
Free Cash Flow
+34.5% YoY
-7.9%
Gross Margin
-4882.0%
Op. Margin
-4420.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-34.6%
ROA-25.6%
ROIC-872.9%

Valuation

P/E-2.5
P/B1.0
EV/EBITDA-0.2

Leverage

Debt/Equity0.12
Current Ratio6.64
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z-0.20
Beneish M43.93

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms